share_log
Reuters ·  Mar 26 10:20
Adaptimmune Therapeutics PLC : Guggenheim Cuts Target Price to $1.75 From $3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 272
Write a comment